Search Results for: Andrew Blevins and Andrew Carrington

Excitement around the transformative potential of AI and machine learning continues to build. Companies will need to adapt their individual offers to draw in AI specialists, but as an industry UK pharma should also continue to champion itself and the unique career advantages it holds for the best and brightest researchers.

The developers expanding the Cambridge Biomedical Campus explain how a cross-sector community of organisations is working to deliver better patient outcomes